Andrzej Mackiewicz
Overview
Explore the profile of Andrzej Mackiewicz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
118
Citations
3907
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Grzechowiak I, Gras J, Szymanska D, Biernacka M, Guglas K, Poter P, et al.
Diagnostics (Basel)
. 2020 Aug;
10(8).
PMID: 32824814
Background: Head and neck squamous cell carcinomas are a group of heterogeneous diseases that occur in the mouth, pharynx and larynx and are characterized by poor prognosis. A low overall...
32.
Mackiewicz J, Mackiewicz A
Ann Transl Med
. 2020 Aug;
8(14):898.
PMID: 32793742
No abstract available.
33.
Kozlowska J, Koziol K, Stasiak M, Obacz J, Guglas K, Poter P, et al.
Contemp Oncol (Pozn)
. 2020 Aug;
24(2):96-105.
PMID: 32774134
Introduction: Nuclear paraspeckle assembly transcript 1 () is considered an oncogene in various cancers, but the role in head and neck squamous cell carcinomas (HNSCC) is not clear. Material And...
34.
Kazimierczak U, Kolenda T, Kowalczyk D, Mackiewicz J, Mackiewicz A
Anticancer Res
. 2020 Jul;
40(7):3723-3732.
PMID: 32620611
Background/aim: Skin melanoma belongs to the most invasive malignancies with no cure for a progressing disease. Personalized therapy would allow for the selection of patients that will benefit from treatment....
35.
Ascierto P, Del Vecchio M, Mackiewicz A, Robert C, Chiarion-Sileni V, Arance A, et al.
J Immunother Cancer
. 2020 Jun;
8(1).
PMID: 32503946
Background: We have previously reported significantly longer overall survival (OS) with ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with advanced melanoma, with higher incidences of adverse events (AEs)...
36.
Florczak A, Jastrzebska K, Mackiewicz A, Dams-Kozlowska H
J Mater Chem B
. 2020 Apr;
5(16):3000-3011.
PMID: 32263992
Bioengineered spider silk is a material that combines superb mechanical properties, biocompatibility and biodegradability with simple production and purification procedures. Moreover, genetic engineering enables the functionalization of silk by adding...
37.
Kucharczyk K, Florczak A, Deptuch T, Penderecka K, Jastrzebska K, Mackiewicz A, et al.
J Nanobiotechnology
. 2020 Apr;
18(1):56.
PMID: 32228620
Background: The optimal drug delivery system should be biocompatible, biodegradable, and allow the sustained release of the drug only after it reaches the target cells. Silk, as a natural polymer,...
38.
Gabka-Buszek A, Kwiatkowska-Borowczyk E, Jankowski J, Kozlowska A, Mackiewicz A
Vaccines (Basel)
. 2020 Apr;
8(2).
PMID: 32224883
Therapeutic cancer vaccines have elicited renewed interest due to the development of immune checkpoint inhibitors. The role of these vaccines is to induce specific effector cells for killing cancer cells....
39.
Florczak A, Mackiewicz A, Dams-Kozlowska H
Int J Nanomedicine
. 2020 Feb;
14:6855-6865.
PMID: 32021156
Background: The development of nanocarrier technology has attracted great interest in the last decade. Biodegradable spheres made of functionalized silk have considerable potential to be used as drug delivery systems...
40.
Czerwinska P, Rucinski M, Wlodarczyk N, Jaworska A, Grzadzielewska I, Gryska K, et al.
Oncoimmunology
. 2020 Feb;
9(1):1710063.
PMID: 32002306
We developed a therapeutic, gene-modified, allogeneic melanoma vaccine (AGI-101H), which, upon genetic modification, acquired melanoma stem cell-like phenotype. Since its initial clinical trial in 1997, the vaccine has resulted in...